Paediatric rheumatology: a subspecialty in its infancy that is making leaps and bounds

Pei Ling Ooi1, Lynette Pei-Chi Shek

  • 1Department of Paediatrics, Level 12, NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228. pei_ling_ooi@nuhs.edu.sg.

Insights

Paediatric rheumatology is rapidly advancing, offering new treatments for autoimmune and autoinflammatory diseases in children. Increased education is crucial in Asia to ensure children with rheumatic conditions achieve normal daily function.

Area of Science:

  • Rheumatology
  • Paediatric Medicine
  • Immunology

Background:

  • Paediatric rheumatology is a developing subspecialty in Asia.
  • There is a growing body of knowledge regarding autoimmune and autoinflammatory conditions in children.
  • Early diagnosis and treatment are vital for managing paediatric rheumatic diseases.

Purpose of the Study:

  • To highlight the importance of paediatric rheumatology in Asia.
  • To emphasize the need for public and medical community education on paediatric rheumatic diseases.
  • To improve functional outcomes for children with these conditions.

Main Methods:

  • This study is a review and expert opinion piece.
  • It synthesizes current knowledge in paediatric rheumatology.
  • It addresses the educational gap in Asian medical communities.

Main Results:

  • Paediatric rheumatology is experiencing significant growth globally.
  • Asia faces challenges due to its relatively new status in this subspecialty.
  • Effective management requires a well-informed public and medical professionals.

Conclusions:

  • Educating the public and medical professionals is essential for advancing paediatric rheumatology in Asia.
  • Improved understanding will lead to better outcomes and normal function for affected children.
  • Further initiatives are needed to support this growing field in the region.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
539
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960